Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04420702 · ClinicalTrials.gov registry record · NA

Diffusion Basis Spectrum Imaging of the Prostate

A NA study of Prostate Cancer, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT04420702 is a NA study of Prostate Cancer that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 500 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04420702, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

Diffusion Basis Spectrum Imaging (DBSI) represents a potential leap forward in improving prostate cancer early detection: a non-invasive and accurate imaging test for clinically significant prostate cancer.

Conditions Studied

Interventions

  • DEVICE MRI with DBSI analysis

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2020-02-27
Est. Completion 2027-05-31
Phase NA

What the Registry Record Tells You About NCT04420702

The ClinicalTrials.gov registry entry for NCT04420702 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (18% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which MRI with DBSI analysis is the first listed.

NCT04420702 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT04420702 about?

NCT04420702 is a clinical study titled "Diffusion Basis Spectrum Imaging of the Prostate". Diffusion Basis Spectrum Imaging (DBSI) represents a potential leap forward in improving prostate cancer early detection: a non-invasive and accurate imaging test for clinically significant prostate cancer.

What is the current status of trial NCT04420702?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2020-02-27. Estimated completion is 2027-05-31.

What conditions does trial NCT04420702 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT04420702?

The interventions under investigation include: MRI with DBSI analysis (DEVICE).

Who is sponsoring clinical trial NCT04420702?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04420702 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.